Nine top tips to save while you’re on holiday

Check out these tips for keeping costs down so that you can enjoy the summer abroad

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

70.36

+1.28

(+1.85%)

As of 01:16PM EDT. Market open.

Loading interactive chart…

Zacks
Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Tops Revenue Estimates
Beam Therapeutics Inc. (BEAM) delivered earnings and revenue surprises of 5.56% and 26.87%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Simply Wall St.
Even after rising 8.2% this past week, Beam Therapeutics (NASDAQ:BEAM) shareholders are still down 40% over the past year
Beam Therapeutics Inc. ( NASDAQ:BEAM ) shareholders will doubtless be very grateful to see the share price up 78% in...
Motley Fool
Why Beam Therapeutics Stock Dipped Today
Beam Therapeutics (NASDAQ: BEAM), a pre-clinical gene-editing company, saw its shares dip by as much as 9.8% in early morning trading Monday. Ahead of the opening bell, Beam announced that the Food and Drug Administration (FDA) placed a clinical hold on its relapsed/refractory T-cell acute lymphoblastic leukemia candidate known as BEAM-201. Beam didn't provide a reason for the clinical hold in its early morning press release.